Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Efficacy and safety of baricitinib in patients with active rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitors: Summary results from the 24-week phase III RA-Beacon study

Research output: Contribution to journalConference abstract in journalResearchpeer-review

  • O. Zamani
  • B. Combe
  • H.-P. Tony
  • J. S. Burson
  • H. Tahir
  • Mikkel Østergaard
  • B. Augendre-Ferrante
  • A. Beselin
  • E. Larsson
  • M. Casillas
  • J. Smolen
View graph of relations
Original languageEnglish
Article numberI93
JournalRheumatology (Oxford, England)
Volume55
Issue numberSuppl. 1
ISSN1462-0324
DOIs
Publication statusPublished - 2016

ID: 49911430